OpenAlex
PricingAboutJobs
Log inGet started
Work

Discovery of a Potent and Orally Bioavailable Hypoxia-Inducible Factor 2α (HIF-2α) Agonist and Its Synergistic Therapy with Prolyl Hydroxylase Inhibitors for the Treatment of Renal Anemia

HTML

Year: 2021
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.1c01479
Authors: Yancheng Yu, Fulai Yang, Quanwei Yu, Simeng Liu, Chenyang Wu, Kaijun Su, Le Yang, Xiaoqian Bao, Zhihong Li, Xiang Li, Xiaojin Zhang
Institutions: China Pharmaceutical University, State Key Laboratory of Natural Medicine
Language: English

Topic: Erythropoietin and Anemia Treatment
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: HIF-2, anemia of chronic kidney disease, prolyl hydroxylase inhibitors, oral bioavailability, erythropoietin, synergistic combination therapy, drug discovery
SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, Government of Jiangsu Province, Six Talent Peaks Project in Jiangsu Province
Awards: G6180476585, G8204179753, G904408397
OpenAlex ID: W3210285476
FWCI: 2.386
Cites: 61
Cited by: 30
Related to: 10
Parts: 8
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security